ATE59549T1 - Verpamil in dosierungskapsel. - Google Patents

Verpamil in dosierungskapsel.

Info

Publication number
ATE59549T1
ATE59549T1 AT87301155T AT87301155T ATE59549T1 AT E59549 T1 ATE59549 T1 AT E59549T1 AT 87301155 T AT87301155 T AT 87301155T AT 87301155 T AT87301155 T AT 87301155T AT E59549 T1 ATE59549 T1 AT E59549T1
Authority
AT
Austria
Prior art keywords
verpamil
dosage capsule
capsule
dosage
verapamil
Prior art date
Application number
AT87301155T
Other languages
English (en)
Inventor
Sally I Stephens
Paul Magruder
Patrick S-L Wong
Larry G Hamel
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of ATE59549T1 publication Critical patent/ATE59549T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT87301155T 1986-03-19 1987-02-10 Verpamil in dosierungskapsel. ATE59549T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/841,144 US4753802A (en) 1986-03-19 1986-03-19 Verapamil dosage form
EP87301155A EP0238189B1 (de) 1986-03-19 1987-02-10 Verpamil in Dosierungskapsel

Publications (1)

Publication Number Publication Date
ATE59549T1 true ATE59549T1 (de) 1991-01-15

Family

ID=25284138

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87301155T ATE59549T1 (de) 1986-03-19 1987-02-10 Verpamil in dosierungskapsel.

Country Status (12)

Country Link
US (1) US4753802A (de)
EP (1) EP0238189B1 (de)
JP (1) JPH0798748B2 (de)
KR (1) KR900003385B1 (de)
AT (1) ATE59549T1 (de)
AU (1) AU587307B2 (de)
CA (1) CA1261703A (de)
DE (1) DE3766858D1 (de)
ES (1) ES2019632B3 (de)
GR (1) GR3001290T3 (de)
MX (1) MX174161B (de)
ZA (1) ZA871031B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4690683A (en) * 1985-07-02 1987-09-01 Rutgers, The State University Of New Jersey Transdermal varapamil delivery device
US4816263A (en) * 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
US4859470A (en) * 1988-06-02 1989-08-22 Alza Corporation Dosage form for delivering diltiazem
AU621182B2 (en) * 1989-01-30 1992-03-05 Alza Corporation Dosage form for administering calcium antagonist
FI900470A7 (fi) * 1989-01-31 1990-08-01 Ipa Int Pharma Agentur Gmbh Aktiiviaineita säädetysti vapauttava systeemi ja menetelmä sen valmistamiseksi
DD295760A5 (de) * 1989-01-31 1991-11-14 Martin-Luther-Universitaet Halle Wittenberg,De Arzneistoffreigabesystem mit kotrollierter wirkstoffreisetzung
US5364635A (en) * 1989-09-28 1994-11-15 Knoll Ag Solid drug form with a high verapamil content
NZ238867A (en) * 1990-07-12 1993-08-26 Alza Corp Dosage form for delayed release comprising pharmaceutically active substance and a drug-release hindering means and a second composition which imbibes fluid, expands, and ejects the active substance from the device
US6764697B1 (en) 1991-06-27 2004-07-20 Alza Corporation System for delaying drug delivery up to seven hours
US5160744A (en) * 1991-06-27 1992-11-03 Alza Corporation Verapmil therapy
US5435998A (en) * 1994-08-03 1995-07-25 Abelson; Mark B. Treatment of low-tension glaucoma by topical administration of calcium channel blocking agents
US5695781A (en) * 1995-03-01 1997-12-09 Hallmark Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers
US6083532A (en) 1995-03-01 2000-07-04 Duramed Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers and tablet formed therefrom
US6096339A (en) * 1997-04-04 2000-08-01 Alza Corporation Dosage form, process of making and using same
RU2116064C1 (ru) * 1996-12-30 1998-07-27 Закрытое акционерное общество "Пульмомед" Способ получения лекарственной формы с регулируемым выделением лекарственного препарата
UA74141C2 (uk) 1998-12-09 2005-11-15 Дж.Д. Сірл Енд Ко. Фармацевтична композиція на основі тонкоподрібненого еплеренону (варіанти), спосіб її одержання та спосіб лікування розладів, опосередкованих альдостероном (варіанти)
US20060153914A1 (en) * 1999-12-10 2006-07-13 Biovail Laboratories International S.R.L. Chronotherapeutic diltiazem formulations and the administration thereof
US7108866B1 (en) 1999-12-10 2006-09-19 Biovall Laboratories International Srl Chronotherapeutic diltiazem formulations and the administration thereof
JP4848101B2 (ja) * 2001-08-17 2011-12-28 株式会社フジモト・コーポレーション 徐放性マイクロペレット
US20040005359A1 (en) * 2002-06-27 2004-01-08 Cheng Xiu Xiu Controlled release oral dosage form
EP1691789B1 (de) 2003-11-25 2017-12-20 SmithKline Beecham (Cork) Limited Carvedilol-freie base, salze, wasserfreie formen oder solvate davon, entsprechende pharmazeutische zusammensetzungen, formulierungen mit kontrollierter freisetzung und behandlungs- oder abgabeverfahren
EP1686967A4 (de) * 2003-11-25 2012-08-08 Smithkline Beecham Cork Ltd Carvedilol-freie base, salze, wasserfreie formen oder solvate davon, entsprechende pharmazeutische zusammensetzungen, formulierungen mit kontrollierter freisetzung und behandlungs- oder abgabeverfahren
DE102005031868A1 (de) * 2005-07-04 2007-01-18 Biotronik Vi Patent Ag Arzneimitteldepot zur parenteralen, insbesondere intravaskulären Arzneimittelfreisetzung
KR20130010464A (ko) * 2010-03-23 2013-01-28 아스카 세이야쿠 가부시키가이샤 고형 제제

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4265874A (en) * 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4681583A (en) * 1982-12-20 1987-07-21 Alza Corporation System for dispersing drug in biological environment
US4627850A (en) * 1983-11-02 1986-12-09 Alza Corporation Osmotic capsule
GB2150830B (en) * 1983-12-05 1987-08-19 Alza Corp Drug dispenser
CA1266827A (en) * 1984-06-20 1990-03-20 Merck & Co., Inc. Controlled porosity osmotic pump

Also Published As

Publication number Publication date
AU6871587A (en) 1987-09-24
GR3001290T3 (en) 1992-08-26
AU587307B2 (en) 1989-08-10
DE3766858D1 (de) 1991-02-07
CA1261703A (en) 1989-09-26
KR870008594A (ko) 1987-10-19
JPH0798748B2 (ja) 1995-10-25
KR900003385B1 (ko) 1990-05-18
EP0238189B1 (de) 1991-01-02
EP0238189A1 (de) 1987-09-23
ZA871031B (en) 1987-08-04
MX9203557A (es) 1992-09-01
US4753802A (en) 1988-06-28
MX174161B (es) 1994-04-25
ES2019632B3 (es) 1991-07-01
JPS62226924A (ja) 1987-10-05

Similar Documents

Publication Publication Date Title
DE3766858D1 (de) Verpamil in dosierungskapsel.
DE3774264D1 (de) Pseudoephedrin-dosierungsform.
NO883591D0 (no) Dermal administreringsform.
PT89884A (pt) Dispositivo administrador
IT8721411A0 (it) Composizione farmaceutica idrosolubile contenente n acetilsisteina.
NO890505L (no) Vandig blekepreparat.
DK165233C (da) Doseringsventil
KR880701523A (ko) N,n-디알킬알칸아미드로 되는 조성물 및 그 용도
IT8721410A0 (it) Composizione farmaceutica idrosolubile contenente n acetilcisteina.
KR870700356A (ko) 생물학적 활성 공중합체
DE3682960D1 (de) Pharmazeutische praeparate.
DK150944C (da) Kombineret transport- og doseringspumpe
DE3576118D1 (de) Pharmazeutische praeparate.
PT89883A (pt) Dispositivo administrador
NO894990D0 (no) Konvolutt.
FR2566662B1 (fr) Association medicamenteuse utilisee en photochimiotherapie
DE68902056D1 (de) 4-aroylimidazol-2-on enthaltende pharmazeutische zusammensetzung.
FR2640378B1 (fr) Osmometre statique
DE3667915D1 (de) Pharmazeutische zusammensetzung.
NO894255D0 (no) Ny doseringsform.
ATE64535T1 (de) Xylometazolinhaltige pharmazeutische praeparate.
FI854949A7 (fi) Anordning i gascentral.
ATE63285T1 (de) Kombinierter kleidungs- und verpackungskoffer.
ATE50495T1 (de) Pharmazeutische praeparate.
IT8609467A0 (it) Dispositivo di rovesciamento raddrizzamento di calzini.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time